CGMP PDE-5 INHIBITOR PHARMACEUTICAL FORMULATIONS WITH DELAYED RELEASE

摘要

The invention provides controlled-release formulations for oral administration containing a cGMP PDE-5 inhibitor. The formulations are useful, inter alia, in the treatment or prevention of sexual dysfunction.